Notably, CD39+PD-1+CD8+ T cells from the primary tumor and metastatic sites rather than overall CD8+ T cells mediated pulmonary metastatic dormancy, raising the possibility that this cell subpopulation might have better tumor specificity and was positively associated with increased disease-free survival in patients undergoing breast cancer resection (82). This evidence concerns the gene CD8A and breast cancer.